This website requires Javascript for some parts to function propertly. Your experience may vary.

Brussels à Jour: A Hard Pill to Swallow | Hengeler Mueller News
Competition, Antitrust

Brussels à Jour: A Hard Pill to Swallow

In line with the spirit of the time, it seems that the European Commission has set its sights on the pills industry. The legit one, that is. Moving away from its usual take on Article 102 TFEU cases, the Commission is not only targeting the pharma industry with cartel investigations, but also ramping up its antitrust scrutiny. It seems that the Covid honeymoon is over. So, can we expect an enforcement overdose in the coming months and years? Let's discuss.

To the Newsletter.

Latest Articles

Brussels à Jour: The Circus is in Town

BaFin approves for the first time unpaid equity commitment as a Tier 2 ancillary own-fund item, creating a cash-efficient alternative to group-internal own-fund financing

IBA published updated Guidelines on Conflicts of Interest in International Arbitration

Recent Competition, Antitrust Work